Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population.

Berwick M, Begg CB, Armstrong BK, Reiner AS, Thomas NE, Cook LS, Orlow I, Kricker A, Marrett LD, Gruber SB, Anton-Culver H, Millikan RC, Gallagher RP, Dwyer T, Rosso S, Kanetsky PA, Lee-Taylor J.

J Invest Dermatol. 2011 Dec;131(12):2500-3. doi: 10.1038/jid.2011.235. Epub 2011 Aug 11. No abstract available.

PMID:
21833009
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Novel CDKN2A mutation detected in Spanish melanoma pedigree.

de Torre C, Martínez-Escribano J.

Exp Dermatol. 2010 Aug;19(8):e333-5. doi: 10.1111/j.1600-0625.2009.01048.x.

PMID:
20653773
[PubMed - indexed for MEDLINE]
Free Article
3.

Absence of germline epimutation of the CDKN2A gene in familial melanoma.

van Doorn R, Zoutman WH, Gruis NA.

J Invest Dermatol. 2009 Mar;129(3):781-4. doi: 10.1038/jid.2008.287. Epub 2008 Sep 25. No abstract available.

PMID:
18818678
[PubMed - indexed for MEDLINE]
Free Article
4.

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.

Pastorino L, Bonelli L, Ghiorzo P, Queirolo P, Battistuzzi L, Balleari E, Nasti S, Gargiulo S, Gliori S, Savoia P, Abate Osella S, Bernengo MG, Bianchi Scarrà G.

Pigment Cell Melanoma Res. 2008 Dec;21(6):700-9. doi: 10.1111/j.1755-148X.2008.00512.x. Epub 2008 Oct 22.

PMID:
18983535
[PubMed - indexed for MEDLINE]
5.

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG.

Arch Dermatol. 2000 Sep;136(9):1118-22.

PMID:
10987867
[PubMed - indexed for MEDLINE]
6.

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.

Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.

Br J Cancer. 2001 Sep 14;85(6):836-44.

PMID:
11556834
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma.

Berg P, Wennberg AM, Tuominen R, Sander B, Rozell BL, Platz A, Hansson J.

Melanoma Res. 2004 Aug;14(4):251-5.

PMID:
15305154
[PubMed - indexed for MEDLINE]
8.

CDKN2A germline mutations in individuals with cutaneous malignant melanoma.

Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group.

J Invest Dermatol. 2007 May;127(5):1234-43. Epub 2007 Jan 11.

PMID:
17218939
[PubMed - indexed for MEDLINE]
Free Article
9.

Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.

Lukowsky A, Schäfer-Hesterberg G, Sterry W, Voit C.

J Dermatol Sci. 2008 Feb;49(2):163-5. Epub 2007 Sep 24. No abstract available.

PMID:
17890059
[PubMed - indexed for MEDLINE]
10.

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.

Cancer Res. 2000 Dec 15;60(24):6864-7.

PMID:
11156381
[PubMed - indexed for MEDLINE]
Free Article
11.

A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.

Yang G, Niendorf KB, Tsao H.

J Invest Dermatol. 2004 Sep;123(3):574-5.

PMID:
15304098
[PubMed - indexed for MEDLINE]
Free Article
12.

Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain.

Nagore E, Montoro A, Oltra S, Ledesma E, Botella-Estrada R, Millán JM, Oliver V, Fortea JM, Guillén C.

Melanoma Res. 2005 Dec;15(6):555-8. No abstract available.

PMID:
16314743
[PubMed - indexed for MEDLINE]
13.

Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma.

Stratigos AJ, Yang G, Dimisianos R, Nicolaou V, Stefanaki I, Katsambas AD, Tsao H.

J Invest Dermatol. 2006 Feb;126(2):399-401.

PMID:
16374456
[PubMed - indexed for MEDLINE]
Free Article
14.

A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.

Lang JM, Shennan M, Njauw JC, Luo S, Bishop JN, Harland M, Hayward NK, Tucker MA, Goldstein AM, Landi MT, Puig S, Gruis NA, Bergman W, Bianchi-Scarra G, Ghiorzo P, Hogg D, Tsao H.

J Invest Dermatol. 2011 Feb;131(2):480-6. doi: 10.1038/jid.2010.331. Epub 2010 Nov 18.

PMID:
21085193
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prevalence of 9p21 deletions in UK melanoma families.

Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT.

Genes Chromosomes Cancer. 2005 Nov;44(3):292-300.

PMID:
16032697
[PubMed - indexed for MEDLINE]
16.

Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.

Jovanovic B, Egyhazi S, Eskandarpour M, Ghiorzo P, Palmer JM, Bianchi Scarrà G, Hayward NK, Hansson J.

J Invest Dermatol. 2010 Feb;130(2):618-20. doi: 10.1038/jid.2009.287. Epub 2009 Sep 17. No abstract available.

PMID:
19759551
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.

Yang XR, Jessop L, Myers T, Amundadottir L, Pfeiffer RM, Wheeler W, Pike KM, Yuenger J, Burdett L, Yeager M, Chanock SJ, Tucker MA, Goldstein AM.

Fam Cancer. 2011 Sep;10(3):545-8. doi: 10.1007/s10689-011-9447-9.

PMID:
21614589
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations.

Spica T, Portela M, Gérard B, Formicone F, Descamps V, Crickx B, Ollivaud L, Archimbaud A, Dupin N, Wolkenstein P, Vitoux D, Lebbe C, Saiag P, Basset-Seguin N, Fargnoli MC, Grandchamp B, Peris K, Soufir N; MELAN-COHORT.

J Invest Dermatol. 2006 Jul;126(7):1657-60. Epub 2006 Apr 13. No abstract available.

PMID:
16614725
[PubMed - indexed for MEDLINE]
Free Article
19.

Detection of a rare CDKN2A intronic mutation in a Hungarian melanoma-prone family and its role in splicing regulation.

Balogh K, Széll M, Polyánka H, Pagani F, Bussani E, Kemény L, Oláh J.

Br J Dermatol. 2012 Jul;167(1):131-3. doi: 10.1111/j.1365-2133.2012.10864.x. Epub 2012 May 18.

PMID:
22292911
[PubMed - indexed for MEDLINE]
20.

Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?

Pollio A, Tomasi A, Seidenari S, Pellacani G, Rodolfo M, Frigerio S, Maurichi A, Turchetti D, Bassoli S, Ruini C, Ponti G.

Pigment Cell Melanoma Res. 2013 Sep;26(5):755-7. doi: 10.1111/pcmr.12122. Epub 2013 Jun 27. No abstract available.

PMID:
23802662
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk